Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
40 participants
INTERVENTIONAL
2021-12-10
2022-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diode Laser on the Reversal of Inferior Alveolar Nerve Block Anesthesia in Children
NCT05648981
Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients
NCT01474382
Reversal of Anaesthesia with Diode Laser
NCT06841120
Effectiveness of Phentolamine Mesylate as a Reversing Agent for Local Anesthesia in Children
NCT05448807
Evaluation of the Anti-anaesthetic Effects of Low-Level Laser Therapy on Children's Soft Tissue
NCT06193460
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
subgroup 1: Articaine 4% with 1:100000 epinephrin \&Subgroup 2: Articaine 4% with 1:200000 epinephrin After 30 min of injection corresponding to approximate time of treatment, the patient in each group will be exposed to the reversal agent which may be diode laser or oraverse.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
laser group
Patients will be undergoing anesthesia revision by diode laser
diode laser
patient exposed to diode laser
oraverse group
Patients will be undergoing anesthesia revision by oraverse
OraVerse Injectable Product
injection of oraverse,
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OraVerse Injectable Product
injection of oraverse,
diode laser
patient exposed to diode laser
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Cooperative children aged 6 to 10 years old with the ability to understand and respond to the sensation of soft tissue -
6 Years
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
sara nabil
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
sara nabil
Lecturer of pediatric dentistry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr.sara nabil
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AlAzhar
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.